Cancer treatment is riddled with pros and cons, trade-offs. During October, breast cancer awareness month, the spotlight shines on endocrine therapy or "hormonal therapy." The drug, Tamoxifen, and others like it that shut ...
Oct 18, 2023
0
0
Children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab, a new study reports.
Oct 18, 2023
0
55
Artificial intelligence (AI) has made a grand entrance into the public debate this year, but researchers have long been investigating its potential to transform cancer care and improve patient outcomes. Dedicated sessions ...
Oct 16, 2023
0
0
Nearly 30 million Chinese individuals experience hearing loss (HL), with around 60% of these cases being hereditary. HL is the second most common congenital disability in China, with an estimated 30,000 babies in China born ...
Oct 12, 2023
0
1
What if we could engineer our immune system to make the human body better at fighting cancer? Professor Roy Mariuzza is part of a major research effort aimed at doing just that. An expert in the structural biology of immune ...
Oct 12, 2023
0
2
A recent survey has identified differing opinions between the lay public and trained scientists on genome editing research using human embryos, which will help to guide future bioethical and policy discussions with the lay ...
Oct 12, 2023
0
13
A new editorial perspective was published in Oncotarget, titled "STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma."
Oct 10, 2023
0
1
In recent years, interest in psychedelics and their possible benefit in treating psychiatric illnesses has been revived. Expectations are high, especially in obsessive-compulsive disorder, where patients' therapeutic options ...
Oct 6, 2023
0
160
African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but Vanderbilt University Medical Center (VUMC) researchers have ...
Oct 6, 2023
0
22
A new review paper titled "UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology" has been published in Oncotarget.
Oct 5, 2023
0
6
